30.37
BATS BZX Real-Time Price
As of 11:11am ET
 +0.07 / +0.23%
Today’s Change
29.10
Today|||52-Week Range
47.82
-28.22%
Year-to-Date
Generic Drugmakers Down on Allegations of Price Fixing
10:05am / Zacks.com - Paid Partner Content
AbbVie Settles With Pfizer for Humira Biosimilar in U.S.
Dec 03 / Zacks.com - Paid Partner Content
Mylan (MYL) Down 9.5% Since Last Earnings Report: Can It Rebound?
Dec 05 / Zacks.com - Paid Partner Content
Theravance Pipeline Strong, Plans Yupelri Launch by Year End
Nov 29 / Zacks.com - Paid Partner Content
Mylan Expands Recall of Valsartan to All Unexpired Lots
Dec 05 / Zacks.com - Paid Partner Content
Teva (TEVA) Launches First Generic Version of Mylan's EpiPen
Nov 28 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close30.30
Today’s open30.63
Day’s range30.28 - 30.75
Volume92,588
Average volume (3 months)5,083,407
Market cap$17.2B
Data as of 11:11am ET, 12/11/2018

Growth & Valuation

Earnings growth (last year)+38.30%
Earnings growth (this year)+3.03%
Earnings growth (next 5 years)+6.50%
Revenue growth (last year)+7.06%
P/E ratio29.2
Price/Sales1.91
Price/Book1.31

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+0.40+0.43%
INCYIncyte Corp-0.05-0.08%
ALXNAlexion Pharmaceutic...+1.95+1.70%
JAZZJazz Pharmaceuticals...+3.50+2.51%
Data as of 11:11am ET, 12/11/2018

Financials

Next reporting dateFebruary 27, 2019
EPS forecast (this quarter)$1.42
Annual revenue (last year)$11.9B
Annual profit (last year)$696.0M
Net profit margin5.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts